355 related articles for article (PubMed ID: 20936945)
1. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
Krishnan AV; Feldman D
Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity.
Krishnan AV; Moreno J; Nonn L; Swami S; Peehl DM; Feldman D
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V74-80. PubMed ID: 18290727
[TBL] [Abstract][Full Text] [Related]
4. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
[TBL] [Abstract][Full Text] [Related]
5. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
6. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.
Krishnan AV; Moreno J; Nonn L; Malloy P; Swami S; Peng L; Peehl DM; Feldman D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):694-702. PubMed ID: 17229571
[TBL] [Abstract][Full Text] [Related]
7. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
Moreno J; Krishnan AV; Peehl DM; Feldman D
Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D - pivotal nutraceutical in the regulation of cancer metastasis and angiogenesis.
Xu J; Li W; Ma J; Liu J; Sha H; Zhou S; Wang F; Ma Q
Curr Med Chem; 2013; 20(33):4109-20. PubMed ID: 23895682
[TBL] [Abstract][Full Text] [Related]
10. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
Moreno J; Krishnan AV; Feldman D
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):31-6. PubMed ID: 16024246
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
14. The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃.
Vanoirbeek E; Krishnan A; Eelen G; Verlinden L; Bouillon R; Feldman D; Verstuyf A
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):593-604. PubMed ID: 21872801
[TBL] [Abstract][Full Text] [Related]
15. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.
Krishnan AV; Swami S; Peng L; Wang J; Moreno J; Feldman D
Endocrinology; 2010 Jan; 151(1):32-42. PubMed ID: 19906814
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of vitamin D anticancer activity.
Picotto G; Liaudat AC; Bohl L; Tolosa de Talamoni N
Cancer Invest; 2012 Oct; 30(8):604-14. PubMed ID: 22963190
[TBL] [Abstract][Full Text] [Related]
17. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
20. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.
Liby KT; Yore MM; Sporn MB
Nat Rev Cancer; 2007 May; 7(5):357-69. PubMed ID: 17446857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
